Global Clinical Site Assessment Limited

Registered number

12454516

Filleted Accounts

31 March 2025

Global Clinical Site Assessment Limited
Registered number:		12454516
Balance Sheet
as at 31 March 2025


Notes			2025			2024
£				£
Current assets
Debtors	3	77,193			47,524
Cash at bank and in hand		5,650			18,007
		82,843			65,531

Creditors: amounts falling due within one year	4	(280,060)			(224,780)

Net current liabilities			(197,217)			(159,249)

Net liabilities			(197,217)			(159,249)

Capital and reserves
Called up share capital			1			1
Profit and loss account			(197,218)			(159,250)

Shareholders' funds			(197,217)			(159,249)

The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.



…...............................
J Johnson North
Director
Approved by the board on 29 December 2025

Global Clinical Site Assessment Limited
Notes to the Accounts
for the year ended 31 March 2025


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Going concern
	The financial statements have been prepared on the going concern basis. The company relies on financial support from its parent company and a fellow subsidiary to meet its working capital requirements. The director is of the opinion that forecasts and improved trading together with support from group companies is sufficient to conclude that the company can continue as a going concern.

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Provisions
	Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.


2	Employees	2025		2024
Number			Number

	Average number of persons employed by the company	1		1


3	Debtors	2025		2024
£			£

	Trade debtors	44,925		-
	Amounts owed by group undertakings and undertakings in which the company has a participating interest	17,373		45,145
	Other debtors	14,895		2,379
		77,193		47,524


4	Creditors: amounts falling due within one year	2025		2024
£			£

	Trade creditors	6,482		2,254
	Amounts owed to group undertakings and undertakings in which the company has a participating interest	29,814		10,372
	Other creditors	243,764		212,154
		280,060		224,780


5	Related party transactions

	During the year the company was charged £90,000 by its parent Company Future Shaper Holdings Limited (2024 - £228,400 by its parent company and a fellow subsidiary company) for staff and management charges.


6	Controlling party

	The ultimate controlling party is the director J Johnson North by virtue of her majority holding in the shares of the parent company.


7	Other information

	Global Clinical Site Assessment Limited is a private company limited by shares and incorporated in England. Its registered office is:
	Bray Business Centre
	Monkey Island Lane
	Maidenhead
	Berkshire
	SL6 2ED